Capital Markets Assignment

Hamilton acted for Karo Pharma

Hamilton act­ed for Karo Pharma AB in con­nec­tion with its SEK 800 mil­lion rights is­sue. Karo Pharma is a spe­cial­i­ty phar­ma com­pa­ny that de­vel­ops and mar­kets prod­ucts for phar­ma­cies and di­rect­ly to the health care sec­tor. Karo Pharma has a mar­ket cap­i­tal­i­sa­tion of ap­prox­i­mate­ly SEK 4 bil­lion and is list­ed on Nasdaq Stockholm Mid Cap.